Richard T. Clark
Chairman of the Board, President and Chief Executive Officer, Merck & Co., Inc. Merck Director since 2005.
Leslie A. Brun Chairman and Chief Executive Officer, Sarr Group, LLC (investment holding company). Non-Executive Chairman, Automatic Data Processing, Inc. Director, Philadelphia Media Holdings, LLC and Broadridge Financial Solutions, Inc. Merck Director since July 2008.
Thomas R. Cech, Ph.D.
Director, Colorado Institute for Molecular Biotechnology, University of Colorado. Merck Director since May 2009.
Thomas H. Glocer Chief Executive Officer, Thomson Reuters Corporation (information and services company for businesses and professionals). Director, Thomson Reuters Corporation, Partnership for New York City. Merck Director since 2007.
Steven F. Goldstone Retired Chairman and Chief Executive Officer, RJR Nabisco, Inc.; Managing Partner, Silver Spring Group (private investment firm). Non-Executive Chairman, ConAgra Foods, Inc. Director, Greenhill & Co., Inc. Merck Director since 2007.
William B. Harrison, Jr., Retired Chairman of the Board, JPMorgan Chase & Co. (financial services). Director, Cousins Properties Incorporated and Lincoln Center for the Performing Arts. Merck Director since 1999.
Harry R. Jacobson, M.D. Vice Chancellor, Health Affairs, Emeritus (since June 2009), Vanderbilt University. Non-Executive Chairman, CeloNova BioSciences, Inc. Director, HealthGate Data Corporation, Ingram Industries, Inc. and Kinetic Concepts, Inc. Merck Director since 2007.
William N. Kelley, M.D.
Professor of Medicine, Biochemistry and Biophysics, University of Pennsylvania School of Medicine. Director, Beckman Coulter, Inc., GenVec, Inc., and Polymedix, Inc. Merck Director since 1992.
Rochelle B. Lazarus
Chairman, Ogilvy & Mather Worldwide (advertising and marketing communication company). Director, General Electric, New York Presbyterian Hospital, American Museum of Natural History and World Wildlife Fund. Merck Director since 2004.
Carlos E. Represas Chairman, Nestle Group Mexico. Director, Bombardier Inc. and Vitro S.A. de C.V. Merck Director since February 2009.
Thomas E. Shenk, Ph.D.
Elkins Professor, Department of Molecular Biology, Princeton University. Director, Cell Genesys, Inc. and CV Therapeutics, Inc. Merck Director since 2001.
Anne M. Tatlock Retired Chairman of the Board and Chief Executive Officer, Fiduciary Trust Company International (global asset management services). Director, Fortune Brands, Inc. and Franklin Resources, Inc. Merck Director since 2000.
Samuel O. Thier, M.D.
Lead Director of the Board.
Professor of Medicine and Health Care Policy, Emeritus, Harvard Medical School. Director, Charles River Laboratories, Inc. Merck Director since 1994.
Wendell P. Weeks Chairman and Chief Executive Officer, Corning Incorporated (technology company in telecommunications, information display and advanced materials industries). Director, Corning Incorporated. Merck Director since 2004.
Peter C. Wendell
Managing Director, Sierra Ventures ( technology-oriented venture capital firm). Chairman, Princeton University Investment Company. Merck Director since 2003.
The Merck Code of Conduct - Our Values and Standards: The Basis of our Success discusses the standards that reflect the Company's values and guide day-to-day decision making
Printer Friendly Page
